CARTANA
Stockholm
About CARTANA
CARTANA is a Swedish Biotechnology company that maps gene expression in brain tissue via In Situ Sequencing (ISS), the 4th generation of sequencing technologies. Their solution enables simultaneous analysis of hundreds of genes within all cells comprising a tissue, without losing tissue morphology, with high sensitivity and throughput in several research areas. - Revolutionary research and biomarker discovery - Treatment validation - Future diagnostic tool
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $2.0M
- Funding stage: M&A
- Last round: Series Unknown (Oct 2018)
- Website: cartana.se
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/cartana-143377 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.